Moxifloxacin Difluoro methyl ester
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

141290-02-0Moxifloxacin Difluoro methyl ester

● In Stock

Catalogue No.:VL106016
CAS No.:141290-02-0
Mol. Formula:C15H13F2NO4
Mol. Weight:309.26 g/mol

Additional information on CAS 141290-02-0

Parent drug

Moxifloxacin

IUPAC Name

1-cyclopropyl-6, 7-difluoro-1, 4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid methyl ester

Synonyms

N/A

Description

It is an impurity present in the synthesis of moxifloxacin which is a new 8-methoxy quinolone with enhanced anti-gram positive activity in vitro. It is used in treating community-acquired respiratory tract infection, sinusitis, acute exacerbations of chronic bronchitis, and pneumonia.

References

Kumar, Y. Ravindra., et al. “Structural Identification and Characterization of Impurities in Moxifloxacin.” Journal of Pharmaceutical and Biomedical Analysis, vol. 34, no. 5, Mar. 2004, pp. 1125–29, https://doi.org/10.1016/j.jpba.2003.11.012.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url